BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17364894)

  • 1. A novel lysophospholipid- and pH-sensitive receptor, GPR4, in brain endothelial cells regulates monocyte transmigration.
    Huang F; Mehta D; Predescu S; Kim KS; Lum H
    Endothelium; 2007; 14(1):25-34. PubMed ID: 17364894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4.
    Qiao J; Huang F; Naikawadi RP; Kim KS; Said T; Lum H
    Am J Physiol Lung Cell Mol Physiol; 2006 Jul; 291(1):L91-101. PubMed ID: 16461426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidylcholine induces apoptosis and inflammatory damage in brain microvascular endothelial cells via GPR4-mediated NLRP3 inflammasome activation.
    Liu T; Wang X; Guo F; Sun X; Yuan K; Wang Q; Lan C
    Toxicol In Vitro; 2021 Dec; 77():105227. PubMed ID: 34293432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells.
    Lum H; Qiao J; Walter RJ; Huang F; Subbaiah PV; Kim KS; Holian O
    Am J Physiol Heart Circ Physiol; 2003 Oct; 285(4):H1786-9. PubMed ID: 12805023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4.
    Zhu K; Baudhuin LM; Hong G; Williams FS; Cristina KL; Kabarowski JH; Witte ON; Xu Y
    J Biol Chem; 2001 Nov; 276(44):41325-35. PubMed ID: 11535583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atrial and brain natriuretic peptides on lysophosphatidylcholine-mediated endothelial dysfunction.
    Murohara T; Kugiyama K; Ota Y; Doi H; Ogata N; Ohgushi M; Yasue H
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):870-8. PubMed ID: 10598132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previously postulated "ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms.
    Tobo M; Tomura H; Mogi C; Wang JQ; Liu JP; Komachi M; Damirin A; Kimura T; Murata N; Kurose H; Sato K; Okajima F
    Cell Signal; 2007 Aug; 19(8):1745-53. PubMed ID: 17462861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor.
    Wyder L; Suply T; Ricoux B; Billy E; Schnell C; Baumgarten BU; Maira SM; Koelbing C; Ferretti M; Kinzel B; Müller M; Seuwen K; Ludwig MG
    Angiogenesis; 2011 Dec; 14(4):533-44. PubMed ID: 22045552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation.
    Fujita Y; Yoshizumi M; Izawa Y; Ali N; Ohnishi H; Kanematsu Y; Ishizawa K; Tsuchiya K; Tamaki T
    Endocrinology; 2006 Mar; 147(3):1377-85. PubMed ID: 16322069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying lysophosphatidylcholine-induced potentiation of vascular contractions in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat aorta.
    Matsumoto T; Kobayashi T; Kamata K
    Br J Pharmacol; 2006 Dec; 149(7):931-41. PubMed ID: 17031383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E inhibits lysophosphatidylcholine-induced endothelial dysfunction and platelet activation.
    Murohara T; Ikeda H; Katoh A; Takajo Y; Otsuka Y; Haramaki N; Imaizumi T
    Antioxid Redox Signal; 2002 Oct; 4(5):791-8. PubMed ID: 12470507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidylcholine increases endothelial permeability: role of PKCalpha and RhoA cross talk.
    Huang F; Subbaiah PV; Holian O; Zhang J; Johnson A; Gertzberg N; Lum H
    Am J Physiol Lung Cell Mol Physiol; 2005 Aug; 289(2):L176-85. PubMed ID: 15764646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Ca2+ -activated potassium channels is involved in lysophosphatidylcholine-induced monocyte adhesion to endothelial cells.
    Erdogan A; Schaefer MB; Kuhlmann CR; Most A; Hartmann M; Mayer K; Renner FC; Schaefer C; Abdallah Y; Hoelschermann H; Schaefer CA
    Atherosclerosis; 2007 Jan; 190(1):100-5. PubMed ID: 16600248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner.
    Bektas M; Barak LS; Jolly PS; Liu H; Lynch KR; Lacana E; Suhr KB; Milstien S; Spiegel S
    Biochemistry; 2003 Oct; 42(42):12181-91. PubMed ID: 14567679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human GPR4 and the Notch signaling pathway in endothelial cell tube formation.
    Ren J; Zhang Y; Cai H; Ma H; Zhao D; Zhang X; Li Z; Wang S; Wang J; Liu R; Li Y; Qian J; Wei H; Niu L; Liu Y; Xiao L; Ding M; Jiang S
    Mol Med Rep; 2016 Aug; 14(2):1235-40. PubMed ID: 27279286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidylcholine-induced modulation of Ca(2+)-activated K(+)channels contributes to ROS-dependent proliferation of cultured human endothelial cells.
    Wolfram Kuhlmann CR; Wiebke Lüdders D; Schaefer CA; Kerstin Most A; Backenköhler U; Neumann T; Tillmanns H; Erdogan A
    J Mol Cell Cardiol; 2004 May; 36(5):675-82. PubMed ID: 15135662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidylcholine induces glial cell activation: role of rho kinase.
    Sheikh AM; Nagai A; Ryu JK; McLarnon JG; Kim SU; Masuda J
    Glia; 2009 Jun; 57(8):898-907. PubMed ID: 19115379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidylcholine enhances the suppressive function of human naturally occurring regulatory T cells through TGF-β production.
    Hasegawa H; Lei J; Matsumoto T; Onishi S; Suemori K; Yasukawa M
    Biochem Biophys Res Commun; 2011 Nov; 415(3):526-31. PubMed ID: 22074829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The action mode of lysophosphatidylcholine in human monocytes.
    Yun MR; Okajima F; Im DS
    J Pharmacol Sci; 2004 Jan; 94(1):45-50. PubMed ID: 14745117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Imidazopyridine Compounds as Negative Allosteric Modulators of Proton-Sensing GPR4 in Extracellular Acidification-Induced Responses.
    Tobo A; Tobo M; Nakakura T; Ebara M; Tomura H; Mogi C; Im DS; Murata N; Kuwabara A; Ito S; Fukuda H; Arisawa M; Shuto S; Nakaya M; Kurose H; Sato K; Okajima F
    PLoS One; 2015; 10(6):e0129334. PubMed ID: 26070068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.